NEW COAS IN ONCOLOGY GUIDE
QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.
Read the Guide
Rhode Island, March 18, 2024 — QualityMetric (QM)—an IQVIA business, a leading global clinical outcomes assessments (COA) solutions provider and scientific consultancy specializing in patient-reported outcomes (PRO)—has announced its Smart Measurement System has earned the recent achievement of certified status by HITRUST for information security.
HITRUST Implemented, 1-year (i1) Certification demonstrates that the QualityMetric’s Smart Measurement System is leveraging a set of curated controls to protect against current and emerging threats. The HITRUST i1 Validated Assessment and Certification helps organizations address cybersecurity challenges and remain cyber resilient over time. QualityMetric demonstrates to team members, clients and partners a strong commitment to safeguarding sensitive information, proactively managing risk and remaining a trusted member of the COA community.
“HITRUST is continually innovating to find new and creative approaches to address information security challenges,” said Jeremy Huval, Chief Innovation Officer at HITRUST. “QualityMetric’s HITRUST i1 Certification is the evidence that they are at the forefront of industry best practices for information risk management and cybersecurity.”
QualityMetric is proud to obtain a highly valued and respected certification within the healthcare sector and intends to uphold the operational maturity of its cybersecurity program as an extremely cyber-aware organization.
Learn more about the HITRUST Common Security Framework (CSF) for a deeper understanding of the structured path QualityMetric has taken to achieve certified status.
About QualityMetric
QualityMetric works with the world’s leading healthcare and life sciences companies to measure and better understand outcomes through the creation, administration, and review of general and patient-specific health surveys. Founded in 1997, QM combines its proprietary scientifically validated general health and disease specific surveys with its enabling technology, advanced analytics, and sector expertise to work with all the world’s largest pharmaceutical companies in clinical trials and patient surveillance.
For more information, please visit: QualityMetric.com
Email: [email protected]
